Verkauf durch Sack Fachmedien

Editors-in-Chief: George Miller / Justin Stebbing

Oncogene

Artikelnummer: 9770950923001
Medium: Zeitschrift
ISSN / ISBN: 09509232
Verlag: Springer Nature
Erscheinungsweise: 50 Ausgaben pro Jahr
Kündigungsfrist: 30. September des laufenden Jahres
Lieferfrist: bis zu 10 Tage
Oncogene aims to make substantial advances in our knowledge of processes that contribute to cancer by publishing outstanding research. We propagate work that challenges standard conjecture and builds on previous studies, in particular those that lead to establishing new paradigms in the etio-pathogenesis, diagnosis, treatment, or prevention of cancers, and in processes that drive metastatic spread, and provide important insights into cancer biology beyond what has been revealed thus far. Areas covered by Oncogene include, but are not limited to, the cellular and molecular biology of cancer including resistance to cancer therapies, and development of better approaches to improving survival. Across cancer biology, we have a broad remit encompassing the life sciences and biomedicine, from the most fundamental and theoretical work, through to translational, applied, and clinical research. Reviewing Editors are among the most respected and accomplished individuals in their fields – from genetics and structural biology, to function and mechanism.

Produkteigenschaften


  • Artikelnummer: 9770950923001
  • Medium: Zeitschrift
  • ISBN: 977-095092300-1
  • ISSN: 09509232
  • Verlag: Springer Nature
  • Erscheinungsweise: 50 Ausgaben pro Jahr
  • Sprache(n): Englisch
  • Produktform: Other printed item
  • Ausgabetyp: Kein, Unbekannt